Oct 2026
A Novel Tumor Burden Index to Predict the Prognosis in Stage IA Lung Adenocarcinoma.
Shang-Shang Ma, Xi-Chun Qin, Xin-Jie Xia et al.
· Annals of Surgical Oncology · 0 citations
We have 2 of 7 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Targeting OLR1 may represent a promising strategy to enhance immunotherapy efficacy and improve clinical outcomes in patients with resectable lung cancer, but the study is limited by a relatively small validation cohort and a strong reliance on bioinformatics analyses.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.